BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seevaratnam R, Bocicariu A, Cardoso R, Mahar A, Kiss A, Helyer L, Law C, Coburn N. A meta-analysis of D1 versus D2 lymph node dissection. Gastric Cancer. 2012;15 Suppl 1:S60-S69. [PMID: 22138927 DOI: 10.1007/s10120-011-0110-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Choi YY, An JY, Katai H, Seto Y, Fukagawa T, Okumura Y, Kim DW, Kim HI, Cheong JH, Hyung WJ, Noh SH. A Lymph Node Staging System for Gastric Cancer: A Hybrid Type Based on Topographic and Numeric Systems. PLoS One 2016;11:e0149555. [PMID: 26967161 DOI: 10.1371/journal.pone.0149555] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
2 Jiang L, Yang KH, Guan QL, Zhao P, Chen Y, Tian JH. Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis. J Surg Oncol. 2013;107:807-814. [PMID: 23512524 DOI: 10.1002/jso.23325] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
3 Zhang Y, Zhu Z, Sun Z, Wang Z, Zheng X, Xu H. Preoperative predicting score of lymph node metastasis for gastric cancer. Tumour Biol 2014;35:10437-42. [PMID: 25053600 DOI: 10.1007/s13277-014-2363-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
4 Mocan L. Surgical Management of Gastric Cancer: A Systematic Review. J Clin Med 2021;10:2557. [PMID: 34207898 DOI: 10.3390/jcm10122557] [Reference Citation Analysis]
5 Abbas MN, Bright T, Price T, Karapetis C, Thompson S, Connell C, Watson D, Barnes M, Bull J, Singhal N, Roy A. Patterns of care and outcomes for gastric and gastro-oesophageal junction cancer in an Australian population. ANZ J Surg 2021. [PMID: 34617383 DOI: 10.1111/ans.17249] [Reference Citation Analysis]
6 Biondi A, D'ugo D, Cananzi F, Papa V, Borasi A, Sicoli F, Degiuli M, Doglietto G, Persiani R. Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? European Journal of Surgical Oncology (EJSO) 2015;41:779-86. [DOI: 10.1016/j.ejso.2015.03.227] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
7 Nagem R, Bicalho LG, Lourenço LG. Surgical treatment of gastric cancer in a community hospital in Brazil: who are we treating and how? J Gastrointest Cancer 2013;44:410-6. [PMID: 23812916 DOI: 10.1007/s12029-013-9516-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Kim SH, Chung Y, Kim YH, Choi SI. Oncologic Outcomes after Laparoscopic and Open Distal Gastrectomy for Advanced Gastric Cancer: Propensity Score Matching Analysis. J Gastric Cancer 2019;19:83-91. [PMID: 30944761 DOI: 10.5230/jgc.2019.19.e4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Patti MG, Herbella FA. Indocyanine Green Tracer-Guided Lymph Node Retrieval During Radical Dissection in Gastric Cancer Surgery. JAMA Surg 2020;155:312. [DOI: 10.1001/jamasurg.2019.6034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Lee H, Heo JS, Choi SH, Choi DW. Extended versus peripancreatic lymph node dissection for the treatment of left-sided pancreatic cancer. Ann Surg Treat Res 2017;92:411-8. [PMID: 28580345 DOI: 10.4174/astr.2017.92.6.411] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
11 Yang J, Wang Z, Dong K, Zhang R, Xiao K, Shang L, Li L. Safety and efficacy of indocyanine green fluorescence imaging-guided radical gastrectomy: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol 2021;:1-10. [PMID: 34488515 DOI: 10.1080/17474124.2021.1970530] [Reference Citation Analysis]
12 Zhao B, Huang X, Lu H, Zhang J, Luo R, Xu H, Huang B. Intraoperative blood loss does not independently affect the survival outcome of gastric cancer patients who underwent curative resection. Clin Transl Oncol 2019;21:1197-206. [DOI: 10.1007/s12094-019-02046-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Gamboa-Hoil SI, Adrián PO, Rodrigo SM, Juan Carlos SG, Felix QC. Surgical margins in gastric cancer T2 and T3 and its relationship with recurrence and overall survival at 5 years. Surg Oncol 2020;34:13-6. [PMID: 32103790 DOI: 10.1016/j.suronc.2020.02.018] [Reference Citation Analysis]
14 Quadri HS, Smaglo BG, Morales SJ, Phillips AC, Martin AD, Chalhoub WM, Haddad NG, Unger KR, Levy AD, Al-Refaie WB. Gastric Adenocarcinoma: A Multimodal Approach.Front Surg. 2017;4:42. [PMID: 28824918 DOI: 10.3389/fsurg.2017.00042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
15 Foo M, Leong T. Adjuvant therapy for gastric cancer: Current and future directions. World J Gastroenterol 2014; 20(38): 13718-13727 [PMID: 25320509 DOI: 10.3748/wjg.v20.i38.13718] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
16 Deng J, Zhang R, Pan Y, Wang B, Wu L, Hao X, Liang H. N stages of the seventh edition of TNM Classification are the most intensive variables for predictions of the overall survival of gastric cancer patients who underwent limited lymphadenectomy. Tumour Biol 2014;35:3269-81. [PMID: 24293375 DOI: 10.1007/s13277-013-1428-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
17 Woo Y, Goldner B, Ituarte P, Lee B, Melstrom L, Son T, Noh SH, Fong Y, Hyung WJ. Lymphadenectomy with Optimum of 29 Lymph Nodes Retrieved Associated with Improved Survival in Advanced Gastric Cancer: A 25,000-Patient International Database Study. J Am Coll Surg 2017;224:546-55. [PMID: 28017807 DOI: 10.1016/j.jamcollsurg.2016.12.015] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
18 El-Sedfy A, Dixon M, Seevaratnam R, Bocicariu A, Cardoso R, Mahar A, Kiss A, Helyer L, Law C, Coburn NG. Personalized Surgery for Gastric Adenocarcinoma: A Meta-analysis of D1 versus D2 Lymphadenectomy. Ann Surg Oncol. 2015;22:1820-1827. [PMID: 25348779 DOI: 10.1245/s10434-014-4168-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
19 Kutlu OC, Watchell M, Dissanaike S. Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients. Surg Oncol 2015;24:84-8. [PMID: 25912951 DOI: 10.1016/j.suronc.2015.03.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
20 Gao J, Gao P. Importance of No. 8 lymph node dissection in standard D2 radical gastrectomy for gastric cancer. Shijie Huaren Xiaohua Zazhi 2019; 27(21): 1326-1329 [DOI: 10.11569/wcjd.v27.i21.1326] [Reference Citation Analysis]
21 Pasquer A, Renaud F, Hec F, Gandon A, Vanderbeken M, Drubay V, Caranhac G, Piessen G, Mariette C. Is Centralization Needed for Esophageal and Gastric Cancer Patients With Low Operative Risk?: A Nationwide Study. Annals of Surgery 2016;264:823-30. [DOI: 10.1097/sla.0000000000001768] [Cited by in Crossref: 58] [Cited by in F6Publishing: 14] [Article Influence: 9.7] [Reference Citation Analysis]
22 Kota I, Makoto H, Satoshi K, Yutaka T, Etsuro B, Masanori T. Oncologic feasibility of D1+ gastrectomy for patients with cT1N1, cT2N0-1, or cT3N0 gastric cancer. Eur J Surg Oncol 2021;47:456-62. [PMID: 32919813 DOI: 10.1016/j.ejso.2020.07.031] [Reference Citation Analysis]
23 Kandil MS, Bazarbashi SN, Rahal MM, Al-Shehri AS, Alzahrani AM, Aljubran AH, Zekri JE, Al Olayan AA, Alsharm AA, Yamani NM, Alomary IS, Fagih MA; Saudi Oncology Society. Saudi Oncology Society clinical management guideline series. Gastric cancer 2014. Saudi Med J 2014;35:1529-33. [PMID: 25491224] [Reference Citation Analysis]
24 Peparini N. Beyond T, N and M: The impact of tumor deposits on the staging and treatment of colorectal and gastric carcinoma. Surg Oncol 2018;27:129-37. [PMID: 29937162 DOI: 10.1016/j.suronc.2018.02.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
25 Park SH, Huh H, Choi SI, Kim JH, Jang YJ, Park JM, Kwon OK, Jung MR, Jeong O, Lee CM, Min JS, Kim JJ, An L, Yang KS, Park S, Lee IO; Deep Neuromuscular Block on Oncologic Quality of Laparoscopic Surgery in Obese Gastric Cancer Patients (DEBLOQS_GC) Study Group. Impact of the Deep Neuromuscular Block on Oncologic Quality of Laparoscopic Surgery in Obese Gastric Cancer Patients: A Randomized Clinical Trial. J Am Coll Surg 2022;234:326-39. [PMID: 35213496 DOI: 10.1097/XCS.0000000000000061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Małczak P, Torbicz G, Rubinkiewicz M, Gajewska N, Sajuk N, Rozmus K, Wysocki M, Major P, Budzyński A, Pędziwiatr M. Comparison of totally laparoscopic and open approach in total gastrectomy with D2 lymphadenectomy - systematic review and meta-analysis. Cancer Manag Res 2018;10:6705-14. [PMID: 30584365 DOI: 10.2147/CMAR.S182557] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Bouliaris K, Rachiotis G, Diamantis A, Christodoulidis G, Polychronopoulou E, Tepetes K. Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system. European Journal of Surgical Oncology (EJSO) 2017;43:1350-6. [DOI: 10.1016/j.ejso.2017.03.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
28 Chen QY, Zhong Q, Liu ZY, Huang XB, Que SJ, Zheng WZ, Li P, Zheng CH, Huang CM. Advances in laparoscopic surgery for the treatment of advanced gastric cancer in China. Eur J Surg Oncol 2020;46:e7-e13. [PMID: 32709375 DOI: 10.1016/j.ejso.2020.07.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Santoro R, Ettorre GM, Santoro E. Subtotal gastrectomy for gastric cancer. World J Gastroenterol 2014; 20(38): 13667-13680 [PMID: 25320505 DOI: 10.3748/wjg.v20.i38.13667] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
30 Mrena J, Mattila A, Böhm J, Jantunen I, Kellokumpu I. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer. World J Gastroenterol 2015; 21(47): 13294-13301 [PMID: 26715812 DOI: 10.3748/wjg.v21.i47.13294] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
31 Morgagni P, Nanni O, Carretta E, Altini M, Saragoni L, Falcini F, Garcea D. Lymph node pick up by separate stations: Option or necessity? World J Gastrointest Surg 2015; 7(5): 71-77 [PMID: 26015852 DOI: 10.4240/wjgs.v7.i5.71] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Byun C, Han SU. Current status of randomized controlled trials for laparoscopic gastric surgery for gastric cancer in Korea. Asian J Endosc Surg. 2015;8:130-138. [PMID: 25753372 DOI: 10.1111/ases.12176] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
33 Coburn N, Cosby R, Klein L, Knight G, Malthaner R, Mamazza J, Mercer CD, Ringash J. Staging and surgical approaches in gastric cancer: a clinical practice guideline. Curr Oncol 2017;24:324-31. [PMID: 29089800 DOI: 10.3747/co.24.3736] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
34 Sura K, Ye H, Vu CC, Robertson JM, Kabolizadeh P. How many lymph nodes are enough?-defining the extent of lymph node dissection in stage I-III gastric cancer using the National Cancer Database. J Gastrointest Oncol 2018;9:1168-75. [PMID: 30603138 DOI: 10.21037/jgo.2018.09.07] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
35 Ilson DH. Current Progress in the Adjuvant Treatment of Gastric Cancer. Surgical Oncology Clinics of North America 2017;26:225-39. [DOI: 10.1016/j.soc.2016.10.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
36 Sehdev A, Catenacci DV. Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of care. J Hematol Oncol 2013;6:66. [PMID: 24010946 DOI: 10.1186/1756-8722-6-66] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
37 Liu YY, Fang WL, Wang F, Hsu JT, Tsai CY, Liu KH, Yeh CN, Chen TC, Wu RC, Chiu CT, Yeh TS. Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?-Time to Embrace a New Digit. Oncologist 2017;22:97-106. [PMID: 27789777 DOI: 10.1634/theoncologist.2016-0239] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
38 Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach. J Gastric Cancer 2019;19:1-48. [PMID: 30944757 DOI: 10.5230/jgc.2019.19.e8] [Cited by in Crossref: 103] [Cited by in F6Publishing: 106] [Article Influence: 34.3] [Reference Citation Analysis]
39 Elimova E, Mizrak Kaya D, Harada K, Ajani JA. Potentially Curable Cancers of the Esophagus and Stomach. Mayo Clin Proc 2016;91:1307-18. [PMID: 27594190 DOI: 10.1016/j.mayocp.2016.07.018] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
40 Feng JF, Huang Y, Liu J, Liu H, Sheng HY, Wei WT, Lu WS, Chen DF, Chen WY, Zhou XM. Risk factors for No. 12p and No. 12b lymph node metastases in advanced gastric cancer in China. Ups J Med Sci. 2013;118:9-15. [PMID: 23039019 DOI: 10.3109/03009734.2012.729103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
41 Ko CS, Jheong JH, Jeong SA, Kim BS, Yook JH, Yoo MW, Kim BS, Lee IS, Kim S, Gong CS. Comparison of Standard D2 and Limited Lymph Node Dissection in Elderly Patients with Advanced Gastric Cancer. Ann Surg Oncol 2022. [PMID: 35316435 DOI: 10.1245/s10434-022-11480-w] [Reference Citation Analysis]
42 Kung CH, Song H, Ye W, Nilsson M, Johansson J, Rouvelas I, Irino T, Lundell L, Tsai JA, Lindblad M. Extent of lymphadenectomy has no impact on postoperative complications after gastric cancer surgery in Sweden. Chin J Cancer Res 2017;29:313-22. [PMID: 28947863 DOI: 10.21147/j.issn.1000-9604.2017.04.04] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
43 Faiz Z, Hayashi T, Yoshikawa T. Lymph node dissection for gastric cancer: Establishment of D2 and the current position of splenectomy in Europe and Japan. Eur J Surg Oncol 2021;47:2233-6. [PMID: 33910779 DOI: 10.1016/j.ejso.2021.04.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Degiuli M, De Manzoni G, Di Leo A, D’Ugo D, Galasso E, Marrelli D, Petrioli R, Polom K, Roviello F, Santullo F, Morino M. Gastric cancer: Current status of lymph node dissection. World J Gastroenterol 2016; 22(10): 2875-2893 [PMID: 26973384 DOI: 10.3748/wjg.v22.i10.2875] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 52] [Article Influence: 9.5] [Reference Citation Analysis]
45 Zhao B, Lv W, Lin J. Delaying adjuvant chemotherapy in advanced gastric cancer patients: Risk factors and its impact on survival outcome. Curr Probl Cancer 2020;44:100577. [PMID: 32418615 DOI: 10.1016/j.currproblcancer.2020.100577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Mocellin S, McCulloch P, Kazi H, Gama-Rodrigues JJ, Yuan Y, Nitti D. Extent of lymph node dissection for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2015;:CD001964. [PMID: 26267122 DOI: 10.1002/14651858.CD001964.pub4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
47 Panin SI, Postolov MP, Kovalenko NV, Beburishvili AG, Fedorov AV, Bykov AV. [Distal subtotal gastrectomy and gastreectomy in surgical treatment of patients with gastric cancer: a systematic review and meta-analysis]. Khirurgiia (Mosk) 2020;:93-100. [PMID: 33210514 DOI: 10.17116/hirurgia202011193] [Reference Citation Analysis]
48 Bringeland EA, Wasmuth HH, Fougner R, Mjønes P, Grønbech JE. Impact of perioperative chemotherapy on oncological outcomes after gastric cancer surgery. Br J Surg. 2014;101:1712-1720. [PMID: 25312592 DOI: 10.1002/bjs.9650] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
49 Tuttle R, Hochwald SN, Kukar M, Ben-david K. Total laparoscopic resection for advanced gastric cancer is safe and feasible in the Western population. Surg Endosc 2016;30:3552-8. [DOI: 10.1007/s00464-015-4652-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
50 Peparini N. Digestive cancer surgery in the era of sentinel node and epithelial-mesenchymal transition. World J Gastroenterol 2013; 19(47): 8996-9002 [PMID: 24379624 DOI: 10.3748/wjg.v19.i47.8996] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
51 Giuliani A, Miccini M, Basso L. Extent of lymphadenectomy and perioperative therapies: Two open issues in gastric cancer. World J Gastroenterol 2014; 20(14): 3889-3904 [PMID: 24744579 DOI: 10.3748/wjg.v20.i14.3889] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
52 Wu X, Dong P, Gu J, Li M, Wu W, Lu J, Mu J, Ding Q, Zhang L, Ding Q, Weng H, Liu Y. Combined Portal Vein Resection for Hilar Cholangiocarcinoma: A Meta-analysis of Comparative Studies. J Gastrointest Surg 2013;17:1107-15. [DOI: 10.1007/s11605-013-2202-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
53 Cristina D, Catalin PR, Ovidiu CD, Mihaela P, Cristian GA, Dragos BR, Nicoleta L. D2 Lymphadenectomy as an Independent Prognostic Factor in Gastric Cancer. ARS Medica Tomitana 2020;26:181-7. [DOI: 10.2478/arsm-2020-0036] [Reference Citation Analysis]
54 Verlato G, Giacopuzzi S, Bencivenga M, Morgagni P, Manzoni GD. Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer. World J Gastroenterol 2014; 20(36): 12883-12891 [PMID: 25278685 DOI: 10.3748/wjg.v20.i36.12883] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
55 Orman S, Cayci HM. Gastric cancer: factors affecting survival. Acta Chir Belg 2019;119:24-30. [PMID: 29560799 DOI: 10.1080/00015458.2018.1453437] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
56 Mahmoodzadeh H, Rahimi-Movaghar E, Omranipour R, Shirkhoda M, Jalaeefar A, Miri SR, Sharifi A. The effect of fibrin glue on the postoperative lymphatic leakage after D2-lymphadenectomy and gastrectomy in patients with gastric cancer. BMC Surg 2021;21:155. [PMID: 33745452 DOI: 10.1186/s12893-021-01168-5] [Reference Citation Analysis]
57 Markar SR, Karthikesalingam A, Jackson D, Hanna GB. Long-term survival after gastrectomy for cancer in randomized, controlled oncological trials: comparison between West and East. Ann Surg Oncol. 2013;20:2328-2338. [PMID: 23340695 DOI: 10.1245/s10434-012-2862-9] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.6] [Reference Citation Analysis]
58 Coburn N, Seevaratnam R, Paszat L, Helyer L, Law C, Swallow C, Cardosa R, Mahar A, Lourenco LG, Dixon M. Optimal management of gastric cancer: results from an international RAND/UCLA expert panel. Ann Surg. 2014;259:102-108. [PMID: 23478525 DOI: 10.1097/sla.0b013e318288dd2b] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
59 Tan Z. Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review. Med Sci Monit. 2019;25:3537-3541. [PMID: 31080234 DOI: 10.12659/msm.916475] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 13.3] [Reference Citation Analysis]
60 Chen QY, Xie JW, Zhong Q, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Zheng HL, Li P, Zheng CH, Huang CM. Safety and Efficacy of Indocyanine Green Tracer-Guided Lymph Node Dissection During Laparoscopic Radical Gastrectomy in Patients With Gastric Cancer: A Randomized Clinical Trial.JAMA Surg. 2020;155:300-311. [PMID: 32101269 DOI: 10.1001/jamasurg.2019.6033] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
61 Coburn N, Cosby R, Klein L, Knight G, Malthaner R, Mamazza J, Mercer CD, Ringash J. Staging and surgical approaches in gastric cancer: A systematic review. Cancer Treatment Reviews 2018;63:104-15. [DOI: 10.1016/j.ctrv.2017.12.006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 10.5] [Reference Citation Analysis]
62 de Mestier L, Lardière-Deguelte S, Volet J, Kianmanesh R, Bouché O. Recent insights in the therapeutic management of patients with gastric cancer. Dig Liver Dis. 2016;48:984-994. [PMID: 27156069 DOI: 10.1016/j.dld.2016.04.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
63 Jiang N, Deng JY, Ding XW, Zhang L, Liu HG, Liang YX, Liang H. Effect of complication grade on survival following curative gastrectomy for carcinoma. World J Gastroenterol 2014; 20(25): 8244-8252 [PMID: 25009399 DOI: 10.3748/wjg.v20.i25.8244] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
64 Mocellin S, Nitti D. Lymphadenectomy extent and survival of patients with gastric carcinoma: a systematic review and meta-analysis of time-to-event data from randomized trials. Cancer Treat Rev 2015;41:448-54. [PMID: 25814393 DOI: 10.1016/j.ctrv.2015.03.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
65 Deng JY, Liang H. Clinical significance of lymph node metastasis in gastric cancer. World J Gastroenterol 2014; 20(14): 3967-3975 [PMID: 24744586 DOI: 10.3748/wjg.v20.i14.3967] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 80] [Article Influence: 10.0] [Reference Citation Analysis]